What is Binah.ai?
Founded in 2016, Binah.ai specializes in the development of sophisticated video-based monitoring solutions designed for the healthcare industry. The company utilizes proprietary artificial intelligence to extract vital signs—including oxygen saturation, respiration rate, and heart rate—directly from standard camera feeds. This technology effectively bridges the gap between clinical-grade diagnostics and consumer-accessible hardware, enabling seamless integration into existing telehealth platforms and enterprise health ecosystems. By removing the need for wearable sensors, Binah.ai is redefining the accessibility of remote patient monitoring, positioning itself as a foundational technology provider for the next generation of digital health services.
How much funding has Binah.ai raised?
Binah.ai has raised a total of $13.5M across 1 funding round:
Series B
$13.5M
Series B (2020): $13.5M with participation from Sompo International, Maverick Ventures, iAngels, GiTV, and Esplanade Ventures
Key Investors in Binah.ai
Maverick Ventures
A venture capital firm focused on supporting technology start-ups through capital investment and operational guidance, with a specific interest in AI and healthcare innovation.
iAngels
An investment platform that provides access to high-growth technology companies, connecting investors with innovative startups in the Israeli ecosystem.
Sompo International
A global provider of commercial and consumer property and casualty insurance, often investing in technologies that enhance risk assessment and health outcomes.
What's next for Binah.ai?
With the successful closure of this major strategic investment, Binah.ai is expected to focus on expanding its global footprint and deepening its clinical validation efforts. The company's roadmap likely involves enhancing the precision of its AI algorithms to support a broader range of health indicators, thereby increasing its utility for insurance providers, wellness platforms, and hospital systems. As the firm transitions into a more mature growth phase, the focus will shift toward regulatory compliance and strategic partnerships that facilitate widespread adoption of its non-invasive monitoring technology. The capital injection provides the necessary runway to scale operations and maintain a competitive edge in the rapidly evolving landscape of AI-powered health diagnostics.
See full Binah.ai company page
